https://paradigmbiopharma.com/activity-updates/exWp6y-paradigm-featured-by-the-armchair-analyst 2026-06-22T03:14:44Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/rAox1y 2017-02-28T00:26:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PK1Nwe-exploratory-phase-2-trial-suggests-therapeutic-effects-for-ipps-in-knee-osteoarthritis 2023-03-17T23:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/P4gMor-ipps-effects-on-synovial-fluid-oa-biomarkers 2026-04-09T07:37:30Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PBkvJy-results-of-an-open-label-phase-2-study-evaluating-pps-safety-and-tolerability-in-mps-i 2023-03-13T23:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PwE43e 2023-04-04T01:45:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/P2xZme 2019-05-01T01:32:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yz86br 2025-11-09T22:13:03Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PKEKge-investor-catch-up-ausbiz-capital-investor-connect 2026-03-09T23:44:02Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/eYpGOy-money-news-with-scott-haywood-and-paul-rennie 2026-04-07T22:29:19Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yz8z3r 2023-02-06T00:43:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/rkR1Ee 2016-03-18T00:22:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yzmGBP-paradigm-biopharmaceuticals-2025-agm 2025-11-19T06:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yVdkZr 2022-10-11T00:40:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PwB5Er-mps-vi-defining-and-measuring-functional-impacts-in-pediatric-patients 2021-12-01T23:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/eW1k6P 2020-04-16T01:33:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/epKG6y-paradigm-biopharma-presentation-ausbiz-capital-investor-connect 2025-08-27T08:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PK1g7e-liffort-hobley-reflects-on-pps-outcomes-ahead-of-super-bowl-preview 2026-02-01T06:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/r6wj1P 2024-11-29T00:53:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/P4NZoe 2025-07-01T01:55:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yVnw4y-painweek-2023-abstract 2023-09-05T00:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/Png1oy 2016-06-07T01:24:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yankle 2023-03-02T00:44:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PR1k3r 2024-12-10T00:54:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/y5p53P-ipps-potential-new-osteoarthritis-drug 2023-10-31T07:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/rvQnYe-techknow-webinar-series-presentation 2025-12-03T00:31:38Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/eg0d3r-the-aussie-discovery-that-helped-an-afl-great-get-back-on-his-feet-7news 2025-07-10T08:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/egL15r 2023-07-25T01:50:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yan5Re 2025-10-08T00:09:29Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/Pb30ny-phase-2b-para-005-trial-results-video 2018-12-18T07:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yzmXXP-oarsi-2023-clinical-trial-symposium 2023-03-15T23:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/eo5jbP 2017-03-01T00:28:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/y0V9kr 2019-01-23T00:31:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yabd1e-presentation-paradigm-biopharma-ignite-investment-summit-hong-kong-october-2025 2025-10-21T06:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PdV1Ke 2016-12-15T00:24:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/rL5kqP 2021-06-16T01:36:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/P7Nj5r 2017-02-10T00:25:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/epKQoy-double-blind-placebo-controlled-phase-2-study-to-evaluate-the-safety-tolerability-of-pps-in-subjects-with-mps-vi 2022-02-09T23:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/y0KnnP 2025-11-24T22:55:40Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/exdK3e 2021-03-30T00:35:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/eYO8OP 2016-05-26T01:23:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PlVxke 2021-02-24T00:33:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PBkRQy-paradigm-biopharmaceuticals-par-bell-potter-healthcare-conference-2025 2025-11-21T06:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/epD18e 2023-04-05T01:46:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PRKE5y-oarsi-2024-sponsored-theatre-symposium 2024-04-19T00:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/eg0B0r-an-open-label-single-centre-pilot-study-to-evaluate-the-safety-and-tolerability-of-pps-in-subjects-with-mps-i 2021-11-22T23:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/e9Bj8r 2021-03-11T00:34:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/ej6Lme 2018-03-06T00:30:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PZgo3y 2025-11-28T00:30:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/P3px0y-nwr-virtual-healthcare-conference-presemtatiom 2026-03-29T23:45:27Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/P4NZ4e 2022-11-25T00:41:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yVnB5y-effects-of-pentosan-polysulfate-sodium-on-joint-structure-and-function-out-to-six-months-in-naturally-occurring-canine-osteoarthritis 2026-02-10T06:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/y5paQP-position-statement-pentosan-polysulfate-sodium-pps-and-pigmentary-maculopathy-pm 2025-12-15T23:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yVdk5r 2025-01-31T00:55:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/eN1YKy 2025-10-01T03:17:56Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PKB28r 2021-12-09T00:41:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/P4gxQr-oarsi-2023-sponsored-theatre-symposium 2023-03-17T23:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/r6JVdr-oarsi-2024-podium-presentation 2024-04-03T23:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/rJ10pe-expanded-access-program-results-film 2020-07-30T08:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/Pqa1nP 2016-01-20T00:21:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PR1kkr 2022-10-04T00:39:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/y5njle 2023-10-10T00:52:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yVn4gy-ignite-investor-conference-hong-kong 2026-05-05T23:34:02Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PZpn3e 2015-06-30T01:20:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yab32e-phase-2-study-evaluating-pps-efficacy-and-safety-in-mps-vi 2023-02-23T23:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/yE2j6e 2021-08-03T01:37:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PwB2Gr-paradigm-acquisition-global-ip-for-the-combination-of-pps-and-a-cox-2-inhibitor 2025-06-26T08:00:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/r6wj4P 2021-08-04T01:38:00Z monthly 0.6 https://paradigmbiopharma.com/activity-updates/PB5jpr 2022-12-14T00:42:00Z monthly 0.6